Actively Recruiting
Dorothy P. and Richard P Simmons Center for Interstitial Lung Disease Research Registry
Led by University of Pittsburgh · Updated on 2025-10-29
5000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to collect past, current, and future medical records from individuals treated for interstitial lung disease at the UPMC Simmons Center for Interstitial Lung Disease. The goal is to create a research registry that will help investigators better understand interstitial lung disease and its treatment by studying a large collection of patient data. This registry also supports identifying and recruiting patients for future research studies related to this lung condition. Participants provide permission for their medical records to be included in this research registry. There are no specific treatments or interventions as this is an observational study focused on gathering medical information rather than administering therapies. The registry will continuously collect data from the participants' records over time. During the study, researchers will review the medical records of participants to answer questions about interstitial lung disease. There are no required visits, procedures, or treatments since the study involves only the collection and analysis of medical data. Participation may continue over many years, with ongoing updates to the registry as new medical information becomes available.
CONDITIONS
Brief Title
Dorothy P. and Richard P. Simmons Center for ILD Research Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients who are seeking treatment at the UPMC Simmons Center for Interstitial Lung Disease
- 18 years of age or older
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to July 2035
Participants' past, current, and future medical record information is collected and observed to support research on interstitial lung disease.
Trial Site Locations
Total: 1 location
1
Michelle F MacPherson
Pittsburgh, Pennsylvania, United States, 15213
Actively Recruiting
Research Team
M
Michelle F MacPherson, MAT
M
Michelle Meyers, BSN, RN
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here